Antiviral Phytoremediation for Sustainable Wastewater Treatment

Enteric viruses in wastewater remain a persistent public health threat. Conventional treatments often achieve only modest viral log10 reductions and can generate toxic disinfection byproducts, but high-energy advanced processes are often unaffordable. Antiviral phytoremediation, which involves virus removal mediated by plants and their rhizosphere microbiota, offers a low-cost, low-energy alternative; however, it has scarcely been studied. A bibliometric analysis of ~23,000 wastewater treatment studies (1976–2025) identified only 30 virus-targeted records within plant-based treatment branches, representing ~0.13% of the total corpus. This critical review structures antiviral phytoremediation into a four-barrier framework: (i) sorption/filtration, (ii) rhizosphere-mediated inactivation, (iii) plant internalization, and (iv) intracellular degradation. Pilot and full-scale studies provide strong support for the first two barriers, whereas evidence for internalization and intracellular degradation is limited, mainly laboratory-based, and often inferred from molecular rather than infectivity assays. Standalone constructed wetlands typically achieve ~1–3 log10 virus reductions, but hybrid configurations that combine wetlands with complementary processes achieve ~3–7 log10 reductions, with performance varying between enveloped and non-enveloped viruses and across climates. This review distills design principles for cost-effective hybrid systems and identifies methodological and governance priorities, positioning rigorously designed phytoremediation as a scalable part of climate- and pandemic-resilient wastewater infrastructure.